VIVOSIM LABS INC
VIVS·68620A302·US·Common Stock·Healthcare - Biotechnology-13D/G
VIVS (VIVOSIM LABS INC) is held by 15 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($52,697), GOLDMAN SACHS GROUP INC ($22,983), VANGUARD CAPITAL MANAGEMENT LLC ($21,981). Net institutional sentiment: Mixed.
15
Holders
Avg rating(5 Elite)
$135,901
Total Value
43% (21)
Fund Consensus
6 buying - 8 selling
Who's Trading
ActivistESEsousa Group Holdings LLC9.9%Apr 6, 2026
InsiderGDGobel DavidSell $7KNov 17, 2025
ActivistARArmistice Capital, LLC5.0%May 15, 2025
13F: Insider & Congress:
Showing 1-20 of 21
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer